Cambridge advances AI in drug research
He works at a research center in Cambridge valued at 20 million British pounds, aimed at developing new medicines using artificial intelligence and advanced scientific models. The center focuses on studying diseases and improving the translation of research findings into effective treatments, while reducing reliance on animal testing. It utilizes human tissues, engineered organs, and AI technologies, with the goal of accelerating and refining drug development more accurately and efficiently. The center is expected to contribute to better personalized treatments, as well as lower costs and the time needed to bring new drugs to market.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)